Horizontal GBR with simultaneous implant placement in anterior maxillary teeth
Dr. Ignacio Ginebreda
Spain
Patient: 47 years old, female, no systemic diseases, no oral pathologies.
Clinical situation: Patient comes to dental office 7 days after a motorcycle accident presenting severe trauma in anterior maxillary teeth. Tooth #1.1 presents a complicated oblique crown-root fracture. Tooth 2.1 is avulsed and lost. Tooth 2.2 presents a horizontal fracture at CEJ level.
Surgical solution: Horizontal GBR in areas #2.1 and #2.2 using creos™ syntogain S granules and creos™ xenoprotect collagen membrane. Simultaneous implant placement of N1™ Implants with customized healing abutment and immediate provisionalization.
Restorative solution: Provisional: 2 sets of PMMA screw-retained temporary crowns. Definitive: 2 individual zirconia-layered implant-supported fixed dental prostheses on Universal Abutments TCC.
Surgery dates: Crown lengthening: January 8, 2021, GBR and implant: March 25, 2022.
Total treatment time: 22 months
Tooth position: #2.1 and #2.2
-
Nobel Biocare N1™ system
Change the way you treat patients.
-
creos™ syntogain
Biomimetic bone graft substitute for efficient regeneration.
-
creos™ xenoprotect
A membrane with outstanding handling that facilitates bone gain.
-
Universal Base
Universal Base - abutments, made your way. Versatility you can base your success on.
Sign up for our blog update
Get the latest clinical cases, industry news, product information and more.
© Nobel Biocare Services AG, 2022. All rights reserved. Nobel Biocare, the Nobel Biocare logotype and all other trademarks are, if nothing else is stated or is evident from the context in a certain case, trademarks of Nobel Biocare. Please refer to nobelbiocare.com/trademarks for more information. Product images are not necessarily to scale. Disclaimer: Some products may not be regulatory cleared/released for sale in all markets. Please contact the local Nobel Biocare sales office for current product assortment and availability. For prescription use only. Caution: Federal (United States) law restricts this device to sale by or on the order of a licensed clinician, medical professional or physician. See Instructions For Use for full prescribing information, including indications, contraindications, warnings and precautions. MimetikOss™ has been distributed as creos™ syntogain since January 2023. Legal Manufacturer: Mimetis Biomaterials S.L., Carrer de Cartagena, 245, 3E, Barcelona 08025, Spain and distributed by Nobel Biocare Services AG. Nobel Biocare does not take any liability for any injury or damage to any person or property arising from the use of this clinical case. This clinical case is not intended to recommend any measures, techniques, procedures or products, or give advice, and is not a substitute for medical training or your own clinical judgement as a healthcare professional. Viewers should never disregard professional medical advice or delay seeking medical treatment because of something they have seen in this clinical case. Full procedure is not shown. Certain sequences have been cut.